Patents by Inventor Rangaswamy Govindarajan

Rangaswamy Govindarajan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using thalidomide in combination with irinotecan
    Patent number: 7479499
    Abstract: This invention relates to compositions comprising thalidomide and irinotecan, which can be used in the treatment or prevention of colorectal cancer. The invention also relates to methods of treating or preventing colorectal cancer which comprise the administration of thalidomide and irinotecan to a patient in need of such treatment or prevention. The invention further relates to methods of reducing or avoiding adverse side effects associated with the administration of irinotecan which comprise the administration of thalidomide to a patient in need of such reduction or avoidance.
    Type: Grant
    Filed: May 11, 2005
    Date of Patent: January 20, 2009
    Assignees: Celgene Corporation, Board of Trustees of the University of Arkansas
    Inventors: Rangaswamy Govindarajan, Andrew Zeitlin
  • Methods of using thalidomide in combination with irinotecan
    Publication number: 20050203060
    Abstract: This invention relates to compositions comprising thalidomide and irinotecan, which can be used in the treatment or prevention of colorectal cancer. The invention also relates to methods of treating or preventing colorectal cancer which comprise the administration of thalidomide and irinotecan to a patient in need of such treatment or prevention. The invention further relates to methods of reducing or avoiding adverse side effects associated with the administration of irinotecan which comprise the administration of thalidomide to a patient in need of such reduction or avoidance.
    Type: Application
    Filed: May 11, 2005
    Publication date: September 15, 2005
    Inventors: Rangaswamy Govindarajan, Andrew Zeitlin
  • Compositions and methods for the treatment of colorectal cancer
    Patent number: 6914067
    Abstract: This invention relates to compositions comprising thalidomide and irinotecan, which can be used in the treatment or prevention of colorectal cancer. The invention also relates to methods of treating or preventing colorectal cancer which comprise the administration of thalidomide and irinotecan to a patient in need of such treatment or prevention. The invention further relates to methods of reducing or avoiding adverse side effects associated with the administration of irinotecan which comprise the administration of thalidomide to a patient in need of such reduction or avoidance.
    Type: Grant
    Filed: May 14, 2001
    Date of Patent: July 5, 2005
    Assignee: Celgene Corporation
    Inventors: Rangaswamy Govindarajan, Andrew Zeitlin
  • Compositions and methods for the treatment of colorectal cancer
    Publication number: 20020035091
    Abstract: This invention relates to compositions comprising thalidomide and irinotecan, which can be used in the treatment or prevention of colorectal cancer. The invention also relates to methods of treating or preventing colorectal cancer which comprise the administration of thalidomide and irinotecan to a patient in need of such treatment or prevention. The invention further relates to methods of reducing or avoiding adverse side effects associated with the administration of irinotecan which comprise the administration of thalidomide to a patient in need of such reduction or avoidance.
    Type: Application
    Filed: May 14, 2001
    Publication date: March 21, 2002
    Inventors: Rangaswamy Govindarajan, Andrew Zeitlin